Xplore Technologies Reports Profitable First Quarter Results
Aug 09, 2017 20:05 pm UTC| Business
AUSTIN, Texas, Aug. 09, 2017 -- Xplore Technologies Corp. (NASDAQ:XPLR), a global leader in rugged computing, today reported results for its fiscal 2018 first quarter, ended June 30, 2017. Fiscal First Quarter 2018...
Geron Corporation Reports Second Quarter 2017 Financial Results
Aug 09, 2017 20:05 pm UTC| Business
MENLO PARK, Calif., Aug. 09, 2017 -- Geron Corporation (Nasdaq:GERN) today reported financial results for the three and six months ended June 30, 2017. For the second quarter of 2017, the company reported a net loss...
Aqua Metals Provides Second Quarter 2017 Corporate Update
Aug 09, 2017 20:05 pm UTC| Business
ALAMEDA, Calif., Aug. 09, 2017 -- Aqua Metals, Inc. (NASDAQ:AQMS), which is commercializing a non-polluting electrochemical lead recycling technology called AquaRefining™, has provided a corporate update and announced...
KeyW Reports Second-Quarter 2017 Financial Results
Aug 09, 2017 20:05 pm UTC| Business
Second-quarter revenue from continuing operations of $124.1 million;GAAP EPS from continuing operations of $(0.34), including extraordinary items discussed below;Second-quarter adjusted EBITDA from continuing operations...
Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference
Aug 09, 2017 20:05 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2017 -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ:GBT) today announced that it will present at the 2017 Wedbush PacGrow Healthcare Conference in New York City on Wednesday,...
Athersys Reports Second Quarter 2017 Results
Aug 09, 2017 20:05 pm UTC| Business
CLEVELAND, Aug. 09, 2017 -- Athersys, Inc. (Nasdaq:ATHX) today announced its financial results for the three months ended June 30, 2017. Highlights of the second quarter of 2017 and recent events include: Clinical...
Editas Medicine Announces Second Quarter 2017 Results and Update
Aug 09, 2017 20:03 pm UTC| Business
Leber Congenital Amaurosis type 10 (LCA10) product candidate EDIT-101 made significant progress toward clinical trials Achieved research milestone in Juno Therapeutics, Inc., collaboration CAMBRIDGE, Mass., Aug. 09,...